n a potentially significant policy shift, the Food and Drug Administration plans to stop redacting portions of the resumes submitted by scientific and medical experts who serve on its advisory committees.

The change comes in response to a lawsuit that was filed last year by Public Citizen, a consumer advocacy group, which argued the redactions were unlawful and robbed the public of the opportunity to understand the extent to which any of the expert advisors may have conflicts.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.